http://purl.org/np/RAySK-31Nx... RAySK-31Nx

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/ns/prov#wasQuotedFrom wasQuotedFrom

https://dailymed.nlm.nih.gov/d...79-d0a4-4af7-b09b-96ee5a5b2a37 drugInfo.cfm?setid=2e325d79-d0a4-4af7-b09b-96ee5a5b2a37

Sarah Chenine

2021-04-04T19:34:28.183Z

http://purl.org/np/RAySK-31Nx... RAySK-31Nx

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/ns/prov#value value

Felbamate oral suspension is recommended for use only in those patients who respond inadequately to alternative treatments and whose epilepsy is so severe that a substantial risk of aplastic anemia and/or liver failure is deemed acceptable in light of the benefits conferred by its use

Sarah Chenine

2021-04-04T19:34:28.183Z

http://purl.org/np/RAySK-31Nx... RAySK-31Nx

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://purl.org/np/RAySK-31Nx...#medtherapy medtherapy

http://www.w3.org/ns/prov#wasDerivedFrom wasDerivedFrom

Sarah Chenine

2021-04-04T19:34:28.183Z